by Alfred Poor | November 13, 2014 | Medical
A company named Nevro recently launched an IPO (initial public offering) on Wall Street with runaway success. According to a report in the Silicon Valley Business Journal, the company sold 7 million shares, which is more than the 6.25 million they intended to sell....